Inventor profile of:

Charles Conrad

City:

Spring, Texas

Country:

United States

Published Applications:

24

Last publication date:

2021-09-30

Top Assignees for applications by Charles Conrad

The entities that hold a legal rights for patent applications filed by inventor Conrad Charles:

Recent patent applications by Conrad Charles

Charles Conrad from Spring, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-09-30
US20210301264A1
Chemistry; metallurgy

ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)

#2 | 2020-10-22
US20200330533A1
Human necessities

Biomarkers and combination therapies using oncolytic virus and immunomodulation

#3 | 2019-07-04
US20190201462A1
Human necessities

Adenovirus and immunomodulator combination therapy

#4 | 2019-03-28
US20190093085A1
Chemistry; metallurgy

ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)

#5 | 2016-10-06
US20160289645A1
Chemistry; metallurgy

Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)

#6 | 2016-05-26
US20160143967A1
Human necessities

TREATMENT OF BRAIN CANCER WITH ONCOLYTIC ADENOVIRUS

#7 | 2015-04-02
US20150094343A1
Chemistry; metallurgy

ORALLY BIOAVAILABLE CAFFEIC ACID RELATED ANTICANCER DRUGS

#8 | 2014-12-25
US20140377221A1
Human necessities

Biomarkers and combination therapies using oncolytic virus and immunomodulation

#9 | 2014-08-14
US20140228414A1
Chemistry; metallurgy

Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

#10 | 2013-09-19
US20130244986A1
Human necessities

METHODS OF TREATING SKIN DISORDERS WITH CAFFEIC ACID ANALOGS

#11 | 2013-05-23
US20130129675A1
Human necessities

INTERFERON THERAPIES IN COMBINATION WITH BLOCKADE OF STAT3 ACTIVATION

#12 | 2012-06-14
US20120149738A1
Chemistry; metallurgy

Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)

#13 | 2011-06-30
US20110160151A1
Human necessities

Acetates of 2-deoxy monosaccharides with anticancer activity

#14 | 2011-03-03
US20110053992A1
Chemistry; metallurgy

Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

#15 | 2011-01-06
US20110003758A1
Human necessities

Inhibitors of glycolysis useful in the treatment of brain tumors

#16 | 2010-06-17
US20100152143A1
Human necessities

Methods of treating skin disorders with caffeic acid analogs

#17 | 2010-05-27
US20100130434A1
Human necessities

Hexose Compounds to Treat Cancer

#18 | 2009-09-10
US20090227924A1
Human necessities

PIXILATED BANDAGE

#19 | 2009-02-19
US20090048590A1
Human necessities

SYSTEMS AND METHODS FOR TREATING NAIL-BED FUNGUS THROUGH APPLICATION OF HEAT

#20 | 2008-07-10
US20080167277A1
Human necessities

METHODS OF TREATING SKIN DISORDERS WITH CAFFEIC ACID ANALOGS

#21 | 2008-01-10
US20080008978A1
Human necessities

TREATMENT DEVICE AND METHOD FOR TREATING OR PREVENTING PERIODONTAL DISEASE THROUGH APPLICATION OF HEAT

#22 | 2007-11-08
US20070259316A1
Human necessities

Treatment device and method for treating or preventing periodontal disease through application of heat

#23 | 2007-10-04
US20070232668A1
Chemistry; metallurgy

Orally bioavailable caffeic acid related anticancer drugs

#24 | 2006-11-21
US10677737
-

Methods and devices for the treatment of skin lesions

InventorID:

260699 ⎘